Cargando…

Antitumorigenic Effect of Hsp90 Inhibitor SNX-2112 on Tongue Squamous Cell Carcinoma is Enhanced by Low-Intensity Ultrasound

PURPOSE: The novel Hsp90 inhibitor SNX-2112 showed broad antitumor activity. However, it was still necessary to optimize the therapeutic dosage of SNX-2112 applied on tumors to obtain effective therapy with minimal dose to reduce toxicity. We investigated the role of low-intensity US in promoting an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nan, Chuanchuan, Zheng, Yuyan, Fan, Haidong, Sun, Haipeng, Huang, Shengxing, Li, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434630/ https://www.ncbi.nlm.nih.gov/pubmed/32884285 http://dx.doi.org/10.2147/OTT.S262174

Ejemplares similares

Complex Crystal Structure Determination and in vitro Anti–non–small Cell Lung Cancer Activity of Hsp90(N) Inhibitor SNX-2112
por: Zhao, Dong, et al.
Publicado: (2021)

Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway
por: Hu, Liubing, et al.
Publicado: (2019)

Suppression of Esophageal Cancer Stem-like Cells by SNX-2112 Is Enhanced by STAT3 Silencing
por: Xu, Dan-dan, et al.
Publicado: (2020)

Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL
por: Chen, Timothy L., et al.
Publicado: (2021)

Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112
por: Dong, Dong, et al.
Publicado: (2015)

Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells
por: Goswami, Ria, et al.
Publicado: (2021)

Eosinophils Exert Antitumorigenic Effects in the Development of Esophageal Squamous Cell Carcinoma
por: Jacobse, Justin, et al.
Publicado: (2023)

SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway
por: Cheng, Xiaozhen, et al.
Publicado: (2021)

Cheiloscopy in gender determination: A study on 2112 individuals
por: Thermadam, Tim Peter, et al.
Publicado: (2020)

The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia
por: Kaufman, Kimberley L., et al.
Publicado: (2015)

2112. Voriconazole for Primary Prophylaxis: A Decade of Trends and Outcomes
por: Mourad, Ahmad, et al.
Publicado: (2019)

HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
por: Li, Zi-Nan, et al.
Publicado: (2022)

Radiosynthesis and preclinical evaluation of [(11)C]SNX-ab as an Hsp90α,β isoform-selective PET probe for in vivo brain and tumour imaging
por: Cools, Romy, et al.
Publicado: (2023)

PPARα Ligands as Antitumorigenic and Antiangiogenic Agents
por: Pozzi, Ambra, et al.
Publicado: (2008)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
por: Kerr, Lauren T., et al.
Publicado: (2016)

Adding SNX to the mix: SNX9 drives filopodia biogenesis
por: Lebek, Nadine M., et al.
Publicado: (2020)

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells
por: YAMAMURO, SHUN, et al.
Publicado: (2015)

Abstract 105: Deferoxamine: A Regenerative Therapeutic with Antitumorigenic Potential
por: Donneys, Alexis, et al.
Publicado: (2018)

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Kijima, Toshiki, et al.
Publicado: (2018)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex
por: Qin, Shurong, et al.
Publicado: (2022)

A heterodimeric SNX4–SNX7 SNX-BAR autophagy complex coordinates ATG9A trafficking for efficient autophagosome assembly
por: Antón, Zuriñe, et al.
Publicado: (2020)

SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma
por: Jiang, Pinping, et al.
Publicado: (2021)

Canonical and Non-Canonical Roles of SNX1 and SNX2 in Endosomal Membrane Dynamics
por: Da Graça, Juliane, et al.
Publicado: (2023)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Mechanisms of Hsp90 regulation
por: Prodromou, Chrisostomos
Publicado: (2016)

Regulatory Mechanisms of Hsp90
por: Prodromou, Chrisostomos
Publicado: (2017)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

Organismal Roles of Hsp90
por: van Oosten-Hawle, Patricija
Publicado: (2023)

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
por: Usmani, Saad Z, et al.
Publicado: (2010)

2112. Incidence and outcomes of infections in liver transplant recipients during the first year post-transplant.
por: Alpizar-Rivas, Rodolfo M, et al.
Publicado: (2022)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)

Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
por: Woodford, Mark R., et al.
Publicado: (2016)

Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts
por: Kuroyanagi, Gen, et al.
Publicado: (2022)

SNX1 hugs the curves
por: LeBrasseur, Nicole
Publicado: (2004)

The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells
por: Spiegelberg, Diana, et al.
Publicado: (2015)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_35a35qephlcap765n92c5165ie